Nurix Therapeutics Presents Preclinical Data from Novel IRAK4 Degrader, GS-6791, Demonstrating Potent Inhibition of IL-1 and IL-36 in Vitro and Efficacy in a Model of Dermatitis

Data support advancement of GS-6791 into clinical testing in patients with inflammatory diseases; first-in-human Phase 1 trial in healthy ...
Us Weekly

11 Must-Watch Action Movies on Netflix Right Now (September 2025): ‘Edge of Tomorrow’ and More

At the beginning of September, Tom Cruise‘s 2014 sci-fi action movie Edge of Tomorrow returned to Netflix. It’s not the first time, and it probably won’t be the last time this film has a guest run on ...

Syndax’s Revuforj® (revumenib) Included in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the Treatment of Relapsed or Refractory NPM1 Mutated Acute ...

The Company has submitted a supplemental New Drug Application (sNDA) seeking the approval of revumenib for the treatment of R/R mNPM1 AML. The sNDA has been granted Priority Review by the FDA and ...
Action News Jax

Madison Foglio, Action News Jax

Madison Foglio is a reporter for Action News Jax and joined the team in March 2025. She comes from Albany, Georgia where she worked as a Morning Anchor/MMJ at WALB News 10. While there she covered the ...